Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
    • GP-001 Control of documents
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 Human Resources and Training
    • GP-006 Non-conformity, Corrective and Preventive actions
    • GP-007 Post-market surveillance
    • GP-009 Sales
      • Deprecated
      • Templates
        • T-009-006 Clinical Trial Technical Readiness Checklist
        • T-009-001 Implementation plan
        • T-009-002 Quotation for clinical practice
        • T-009-003 Terms of service and licensing agreement
        • T-009-004 Quotation for clinical research
        • T-009-005 Client FAQ & prompt guide
      • Specific procedures
    • GP-010 Purchases and suppliers evaluation
    • GP-011 Provision of service
    • GP-012 Design, redesign and development
    • GP-013 Risk management
    • GP-014 Feedback and complaints
    • GP-015 Clinical evaluation
    • GP-016 Traceability and identification
    • GP-017 Technical assistance service
    • GP-018 Infrastructure and facilities
    • GP-019 Non-product software validation
    • GP-020 QMS Data analysis
    • GP-021 Communications
    • GP-022 Document translation
    • GP-023 Change control management
    • GP-024 Predetermined Change Control Plan
    • GP-025 Usability and Human Factors Engineering
    • GP-026 Market-specific product requirements
    • GP-027 Corporate Governance
    • GP-028 AI Development
    • GP-029 Software Delivery and Commissioning
    • GP-030 Cyber Security Management
    • GP-031 Training Data Governance
    • GP-032 CE Mark Process (MDR)
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
    • GP-100 Business Continuity (BCP) and Disaster Recovery plans (DRP)
    • GP-101 Information security
    • GP-110 Esquema Nacional de Seguridad
    • GP-200 Remote Data Acquisition in Clinical Investigations
    • GP-600 Equality Planning
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health US Version 1.1.0.0
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
  • Pricing
  • Public tenders
  • Trainings
  • Procedures
  • GP-009 Sales
  • Templates
  • T-009-006 Clinical Trial Technical Readiness Checklist

T-009-006 Clinical Trial Technical Readiness Checklist

Purpose​

This checklist must be completed for every clinical trial project before go-live. It serves as:

  1. A project setup guide — ensuring all mandatory deliverables are produced
  2. An audit-ready documentation index — providing a single point of access to all project documentation
  3. A regulatory traceability map — linking each deliverable to the applicable regulatory requirement

Instructions​

  • Complete all fields for the specific project
  • Each deliverable must be marked as ✅ Complete, 🔄 In Progress, or ❌ Not Started
  • All items must be ✅ Complete before the Technical Readiness Review (Phase 5 of SP-009-011)
  • Approval signatures are required from JD-004, JD-005, and JD-013

Project Information​

FieldValue
Project Name[Enter project name]
Project Record[R-009-001]
Sponsor / CRO[Enter name]
Contract Date[YYYY-MM-DD]
Target Go-Live Date[YYYY-MM-DD]
Project Manager (JD-013)[Enter name]
Technology Manager (JD-007)[Enter name]

Phase 1 — Project Scoping and Device Provisioning​

#DeliverableRegulatory BasisStatusLocation / ReferenceNotes
1.1Device Provisioning Model (BYOD / Vendor-provided) with justificationMDR 17.3, 17.4☐[link]
1.2Minimum Handset Specifications documentedMDR 17.3 (screen size, contrast), 17.4 (hardware, IT security)☐[link]
1.3Handset specifications communicated to sponsor/CROMDR Art 10(11), Annex I §23☐[link]
1.4Image Capture Environmental Guidance preparedMDR 17.3 (external factors)☐[link]
1.5IT Security measures documented (HTTPS, auth, no local persistence)MDR 17.4 (protection against unauthorised access)☐[link]
1.6WebApp Feature Scope Document (included/excluded features)ISO 13485 §7.1☐[link]

Phase 2 — End-to-End Data Flow and Architecture​

#DeliverableRegulatory BasisStatusLocation / ReferenceNotes
2.1Project-specific End-to-End Data Flow DiagramMDR Annex II §1.1(j), ICH GCP E6 R3 §4☐[link]
2.2Project-specific System Architecture Diagram (WebApp, API, AI, storage, CDN, CRO integration)MDR Annex II §1.1(j), MDR Art 10(4)☐[link]
2.3Data input/output interfaces identifiedMDR Annex II §1.1(j)☐[link]
2.4Security boundaries and access controls documentedMDR 17.4, ICH GCP E6 R3 §3.16☐[link]

Phase 3 — WebApp SDLC and CSV Controls​

#DeliverableRegulatory BasisStatusLocation / ReferenceNotes
3.1Core WebApp Development Controls documented (version control, code review, CI/CD, deployment)ISO 13485 §7.3☐[link]
3.2Study-specific Configuration Document (URL, access control, feature toggles, scoring systems, anonymization, data transfer, image requirements)ISO 13485 §7.3, ICH GCP E6 R3 §3.16☐[link]
3.3Functional testing resultsICH GCP E6 R3 §3.16☐[link]
3.4Image capture and upload testing (target devices/browsers)MDR 17.3☐[link]
3.5DIQA validation resultsMDR 17.3☐[link]
3.6Data transfer validation (end-to-end to sponsor/CRO)ICH GCP E6 R3 §4☐[link]
3.7Access control testingICH GCP E6 R3 §3.16☐[link]
3.8Anonymization testing (if applicable)Study protocol☐[link]

Phase 4 — Study Documentation Package​

#DeliverableRegulatory BasisStatusLocation / ReferenceNotes
4.1User Instructions (image capture guidelines, device requirements) for site staff / trial subjectsMDR Art 10(11), Annex I §23☐[link]
4.2Data Transfer Agreement (DTA) signedICH GCP E6 R3 §4☐[link]
4.3Project-specific user instructions prepared and approvedMDR Art 10(11), Annex I §23☐[link]
4.4PACS/DICOM clarification included in study instructionsICON audit recommendation☐[link]
4.5Study-specific instructions reviewed and approvedISO 13485 §4.2☐[link]

Phase 5 — Technical Readiness Review​

#VerificationStatusNotes
5.1All Phase 1-4 deliverables marked as ✅ Complete☐
5.2All documents accessible in project record (R-009-001)☐
5.3Documentation package reviewed for audit readiness☐

Approval​

RoleNameSignatureDate
JD-004 Quality Manager & PRRC[Enter name][YYYY-MM-DD]
JD-005 Technical Manager & PRRC[Enter name][YYYY-MM-DD]
JD-013 Project Manager[Enter name][YYYY-MM-DD]

Decision: ☐ GO — All deliverables complete, project approved for go-live | ☐ NO-GO — Outstanding items identified, go-live deferred


Associated Documents​

ReferenceTitle
SP-009-011Clinical Trial Project Setup and Technical Deliverables for CRO Engagements
SP-009-005Implementation Plan Helpers for Clinical Trials
SP-009-006Integration Workflow Helpers
GP-023Change control management
Previous
Templates
Next
T-009-001 Implementation plan
  • Purpose
  • Instructions
  • Project Information
  • Phase 1 — Project Scoping and Device Provisioning
  • Phase 2 — End-to-End Data Flow and Architecture
  • Phase 3 — WebApp SDLC and CSV Controls
  • Phase 4 — Study Documentation Package
  • Phase 5 — Technical Readiness Review
  • Approval
  • Associated Documents
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)